Himalaya Nutravedics India Limited IPO
Closed22–24 Sep 2026
Latest update:
Subscribed 2.41× (QIB 1.0× · NII 3.9× · Retail 2.6×) · Price band ₹100–₹106 · Closed 24 Sep 2026 · Allotment 25 Sep 2026 (Confirmed) · Lists 29 Sep 2026 (Expected)
What Himalaya Nutravedics India Limited does
Himalaya Nutravedics India Limited is engaged in the manufacturing, marketing and distribution of Ayurvedic formulations and nutraceutical products in India, along with undertaking third-party contract manufacturing for similar companies. The company offers a diversified product portfolio comprising classical (Shastric) Ayurvedic formulations, proprietary Ayurvedic products and nutraceutical supplements across multiple dosage forms such as capsules, tablets, liquid orals and medicated oils.
Himalaya Nutravedics India Limited financials
Rs crore · AnnualLatest year highlighted in green. Sparklines show the trend.
| 2024 | 2025 | 2026 | ||
|---|---|---|---|---|
| Sales | 14 | 21 | 43 | |
| Operating Profit | — | — | — | |
| OPM % | — | — | — | |
| Net Profit | — | — | — | |
| Total Debt | 3 | 2 | 5 |
Himalaya Nutravedics India Limited IPO offer structure
Fresh issue: ₹27 cr
The offer-for-sale component is not stated in what we extracted from the offer document, so the full issue size and the split between the two are unknown. This figure is the fresh issue alone, not the total raise. Fresh issue proceeds go to the company; OFS proceeds go to selling shareholders.
Issue size and split come from a public aggregator rather than the exchange, cross-checked against a second one. The offer document states the offer-for-sale as a share count against a blank amount, so it cannot be read from the document itself.
Himalaya Nutravedics India Limited promoters and holding
- Rohit Asawa: Chairman and Managing Director
- Divya Asawa: Non-Executive Director
- Chanda Asawa: Promoter
- Rama Raju Penmatsa: Promoter
Himalaya Nutravedics India Limited strengths and risks
Company-stated strengths and disclosed risk factors from the offer document.
- We derive a significant portion of our revenue from the sale of products in the Ayurvedic products segment. (p.480)
- We are dependent on and derive a substantial portion of our revenue from certain key customers. (p.480)
- We have historically derived, and may continue to derive, a significant portion of our supply from top 10 suppliers. (p.480)
- Our profitability may be adversely affected upon the expiry of tax benefits available under Section 80-IAC. (p.480)
- Products returned by Stockists upon expiry may adversely affect our revenues, margins and inventory management. (p.481)
Himalaya Nutravedics India Limited market and competition
In our business of Ayurvedic and nutraceutical formulations, we compete with other marketing companies operating on a pan India scale, and regional companies, all involved in the promotion and sale of Ayurvedic and Nutraceutical formulations.
Himalaya Nutravedics India Limited outlook, as the document states it
Initially the moderation in own-brand contribution percentage was primarily on account of the Company's decision to undertake job work manufacturing to establish operational capabilities, build manufacturing expertise, and achieve scale. Subsequently, leveraging the experience and infrastructure thus developed, the Company pivoted towards scaling its own-brand business, resulting in increase in own-brand revenue in FY2026. Revenue growth was further supported by expansion of the Company's distribution network and marketing initiatives across key markets including Kerala, Gujarat, Uttar Pradesh, and Andhra Pradesh.
Never miss an IPO like this
Every upcoming IPO analysed: subscription, GMP and a DRHP breakdown, in your inbox, free. One email when each one opens.
Himalaya Nutravedics India Limited IPO: common questions
When does the Himalaya Nutravedics India Limited IPO open and close?
The Himalaya Nutravedics India Limited IPO is open from 22 Sep 2026 to 24 Sep 2026.
What is the Himalaya Nutravedics India Limited IPO price band?
The price band is ₹100–₹106 per share.
What is the lot size and minimum investment for the Himalaya Nutravedics India Limited IPO?
One lot is 1200 shares, and a retail application must be at least one lot. That is about ₹2,54,400 at the upper end of the band. An HNI application starts above Rs 2 lakh, so the minimum is higher for that category.
How much is the Himalaya Nutravedics India Limited IPO subscribed?
As of 25 Sep 2026 the total subscription is 2.41×.
When are the Himalaya Nutravedics India Limited IPO allotment and listing dates?
Allotment is on 25 Sep 2026, as published. The listing date follows once the exchange confirms it.
How do I check the Himalaya Nutravedics India Limited IPO allotment status?
On the allotment status page published by KFin Technologies, this issue's registrar, and on the exchange's basis of allotment. Those are the primary sources. If the issue was oversubscribed, retail allotment was decided by lottery, so a valid application does not mean shares. We do not hold allotment data and cannot look yours up. How allotment is actually decided →
Sources & method
Subscription and issue data come from the NSE and BSE exchange feeds, with the third-party aggregator, clearly labelled, where an exchange feed is unreachable. DRHP analysis is extracted from the offer document itself, every figure cited to its page. Each figure on the page carries its source and its timestamp.
Grey-market premium (GMP) is unregulated.
Every GMP figure is a self-reported grey-market estimate. No exchange, regulator or clearing body records or audits it, and there is no settlement guarantee or recourse. Shown for context only; never decide on GMP alone. New to GMP? The 30-second explainer → Has GMP actually been right? →
How often do these actually open above the issue price?
Of the 711 SME IPOs that have listed on the NSE since 2016, 563 (79%) opened above their issue price, at a median of +11%. That is the segment's own record, not a forecast for this issue.
Himalaya Nutravedics India Limited IPO allotment status
Allotment is on 25 Sep 2026, as published. Allotment is decided and published by the registrar, not by us. This issue's registrar is KFin Technologies.
Check your allotment on the registrar's own page ↗
We do not hold allotment data and cannot look yours up. If the issue was oversubscribed, retail allotment was decided by lottery, so a valid application does not mean shares. How allotment is actually decided →